v3.24.3
Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2024
Dec. 31, 2023
 [1]
Current Assets:    
Cash and cash equivalents $ 33,591 $ 30,014
Restricted cash 4,903 15,466
Accounts receivable, net (net of allowance for credit losses of $50 and $85, respectively) 52,038 58,729
Inventories 48,014 52,611
Derivative instruments 36 2,412
Other current assets 6,568 9,538
Total current assets 145,150 168,770
Property and equipment, net 238,892 248,748
Other Assets:    
Right of use operating lease assets, net 19,283 22,597
Intangible assets, net 8,057 8,498
Other assets 6,029 5,628
Total other assets 33,369 36,723
Total Assets 417,411 454,241
Current Liabilities:    
Accounts payable 17,205 20,752
Accrued liabilities 14,255 20,205
Current portion – operating leases 4,440 4,333
Derivative instruments 3,394 13,849
Other current liabilities 5,808 6,149
Total current liabilities 45,102 65,288
Long-term debt, net 83,342 82,097
Operating leases, net of current portion 15,740 19,029
Other liabilities 9,302 8,270
Total Liabilities 153,486 174,684
Commitments and Contingencies (Note 6)
Stockholders’ Equity:    
Preferred stock, $0.001 par value; 10,000 shares authorized; Series A: 1,684 shares authorized; no shares issued and outstanding as of September 30, 2024 and December 31, 2023; Series B: 1,581 shares authorized; 927 shares issued and outstanding as of September 30, 2024 and December 31, 2023; liquidation preference of $18,075 as of September 30, 2024 1 1
Common stock, value 77 76
Additional paid-in capital 1,043,501 1,040,912
Accumulated other comprehensive income 2,481 2,481
Accumulated deficit (782,135) (763,913)
Total stockholders’ equity 263,925 279,557
Total Liabilities and Stockholders’ Equity 417,411 454,241
Non-voting common stock    
Stockholders’ Equity:    
Common stock, value
[1] Amounts derived from the audited consolidated financial statements for the year ended December 31, 2023.

Source

PDF HTML
10-Q Filing
ZIP XLS HTML
XBRL